Minimally invasive treatment for eyelid cholesterol deposits
Part of Hormones & metabolism clinical trials.
This trial tests a new minimally invasive procedure using tiny tunnels and a heparin injection to treat xanthelasma (cholesterol deposits under the skin of the eyelids). It may help reduce the appearance of these deposits with less scarring than traditional methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be diagnosed with xanthelasma (cholesterol deposits on your eyelids).
- You must be willing to receive an injection of heparin sodium as part of the treatment.
- You cannot have hemophilia (a bleeding disorder that prevents blood from clotting normally).
- You cannot have coronary heart disease (narrowing of the heart arteries).
- You cannot have had a heart attack (myocardial infarction).
- You cannot have had a stroke (cerebral infarction).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a cream with simvastatin (a cholesterol medicine) to see if it can shrink yellowish fatty bumps called xanthelasma that appear around the eyelids. If you have these bumps and haven't had recent treatments, this might be an option to try a non-surgical approach.
This trial tests if intense pulsed light (IPL), a light therapy often used for skin issues, can safely help chalazion, a small bump on the eyelid caused by a blocked oil gland. It may reduce inflammation and help the bump resolve faster.
This trial compares a specific medicine injection (5-fluorouracil) to treat chalazia, which are non-cancerous eyelid bumps. It may help reduce the bump when other approaches haven’t worked yet.
This Phase 3 study tests a medicine to help prevent abnormal calcium (called ectopic mineralization) from building up in people with pseudoxanthoma elasticum (PXE). It aims to slow or reduce new damage over time.
This trial tests a new medicine, Artisterol, to see if it can lower cholesterol in people with mildly high levels. It may be an option if you haven't tried other treatments or can't take statins.
This trial compares two glaucoma operations to see which works better at lowering eye pressure and keeping the eye stable. It’s for adults with open-angle glaucoma who are eligible for either surgery and can attend follow-up visits.
Hear when a new Xanthelasma Palpebrarum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.